Abstract
Introduction
The incidence of adenocarcinoma of the small bowel is very low in comparison with that of colorectal cancer. Radical surgery is the only curative treatment, and results with chemotherapy and radiotherapy are disappointing. No standard chemotherapy is defined for non-surgical adenocarcinoma of the small bowel. In France, it is usually treated with the same chemotherapy regimens as used for colorectal cancer.
Case Report
We report here the case of a young patient with an initially non-surgical adenocarcinoma of the duodenum treated in a palliative setting with the FOLFOX 4 chemotherapy regimen. After 4 months of treatment, CT scan showed no residual tumor and the patient was well. A multidisciplinary committee decided that a second surgical investigation was necessary, and a duodenal resection was performed, with no residual tumor in the final specimen. After 27 months of follow-up the patient was well and without recurrence.
Conclusion
The FOLFOX 4 regimen seems to be efficacious for some small-bowel adenocarcinomas and can be expected to lead to downstaging. If the outcome of a few months of chemotherapy is favorable, it is appropriate for a multidisciplinary expert committee to consider further surgery. This case underscores the value of multidisciplinary expert committees in scrutinizing therapeutic decisions in rare and difficult cases.
This is a preview of subscription content, log in via an institution to check access.
References
Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel. Presentation, prognostic factors, and outcome of 217 patients. Cancer 2004;101:518–526.
Bauer RL, Palmer ML, Bauer AM, Nava HR, Douglass HO. Adenocarcinoma of the small intestine: 21-year review of diagnosis, treatment, and prognosis. Ann Surg Oncol 1994;1:183–188.
Ouriel K, Adams JT. Adenocarcinoma of the small intestine. Am J Surg 1984;147:66–71.
Barnes G, Romero L, Hess KR, Curley SA. Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1994;1:73–78.
Rose DM, Hochwald SN, Klimstra DS, Brennan MF. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg 1996;183:89–96.
Treadwell TA, White RR. Primary tumors of the small bowel. Am J Surg 1975;130:749–755.
De Franchis R, Rondonotti E, Abbiati C, Beccari G, Signorelli C. Small bowel malignancy. Gastrointest Endosc Clin N Am 2004;14:139–148.
Gill SS, Heuman DM, Mihas AA. Small intestinal neoplasms. J Clin Gastroenterol 2001;33:267–282.
DiSario JA, Burt RW, Vargas H, McWhorter WP. Small bowel cancer: epidemiological and clinical characteristics from a population-based registry. Am J Gastroenterol 1994;89:699–701.
Chow JS, Chen CC, Ahsan H, Neugut AI. A population-based study of the incidence of malignant small bowel tumors: SEER, 1973–1990. Int J Epidemiol 1996;25:722–728.
Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8–31.
Lepage C, Bouvier AM, Manfredi S, Dancourt V, Faivre J. Incidence and management of primary malignant small bowel cancers. A well-defined French population study. Am J Gastroenterol 2006;101:2826–2832.
Pashayan N, Lepage C, Rachet B, Woods LM, Coleman MP. Survival trends for small intestinal cancers in England and Wales, 1971–1990: national population-based study survival trends for small intestinal cancers. Br J Cancer 2006;95:1296–1300.
Severson RK, Schenk M, Gurney JG, Weiss LK, Demers RY. Increasing incidence of adenocarcinomas and carcinoid tumors of the small intestine in adults. Cancer Epidemiol Biomark Prev 1996;5:81–84.
Howe JR, Karnell LH, Menck HR, Scott-Conner C. Adenocarcinoma of the small bowel. Review of the National Cancer Data Base, 1985–1995. Cancer 1999;86:2693–2706.
Lashner BA. Risk factors for small bowel cancer in Crohn’s disease. Dig Dis Sci 1992;37:1179–1184.
Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn’s disease. Gastroenterology 1993;105:1716–1723.
Persson PG, Karlen P, Bernell O, Leijonmarck CE, Broström O, Ahlbom A et al. Crohn’s disease and cancer: a population-based cohort study. Gastroenterology 1994;107:1675–1679.
Neugut AI, Jacobson JS, Suh S, Mukherjee R, Arber N. The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev 1998;7:243–251.
Ito H, Perez A, Brooks DC, Osteen RT, Zinner MJ, Moore FD et al. Surgical treatment of small bowel cancer: a 20-year single institution experience. J Gastrointest Surg 2003;7:925–930.
Hutchins RR, Bani Hani A, Kojodjojo P, Ho R, Snooks SJ. Adenocarcinoma of the small bowel. ANZ J Surg 2001;71:428–437.
Talamonti MS, Goetz LH, Rao S, Joehl RJ. Primary cancers of the small bowel. Analysis of prognostic factors and results of surgical management. Arch Surg 2002;137:564–571.
Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J et al. EUROCARE-3: survival of cancer patients diagnosed 1990–94 results and commentary. Ann Oncol 2003;14(Suppl 5):v61–v118.
Neugut AI, Marvin MR, Rella VA, Chabot JA. An overview of adenocarcinoma of the small intestine. Oncology 1997;11:529–536.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manfredi, S., Thiebot, T., Henno, S. et al. Complete Response of an Initially Non-surgical Adenocarcinoma of the Duodenum to Chemotherapy with the Folfox 4 Regimen. J Gastrointest Surg 13, 2309–2313 (2009). https://doi.org/10.1007/s11605-009-0953-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-009-0953-0